Long-term remission of cervical dystonia induced by treatment with botulotoxin A - Signal of the possible effect on the central dystonic mechanism?;Dlouhodoba remise cervikalni dystonie navozena lecbou botulotoxinem A - Signal moznebo ovlivneni centralniho dystonickeho mechanismu?

Ceska a Slovenska Neurologie a Neurochirurgie

Volumn 61, Issue 3, 1998, Pages 126-137

  Kanovsky P ^a   Streitova H ^a   Daniel, P ^a   Hekerlova R ^a   Bares M ^a   Hortova H ^a   Dufek, J ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Botulinum A; Cervical dystonia; Long term remission

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; DRUG EFFECT; DYSTONIA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PHYSIOTHERAPY; REMISSION; TREATMENT OUTCOME;

EID: 0031838251     PISSN: 12107859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Fahn S. Idiopathic torsion dystonia, In: Calne DB ed. Neurodegenerative disorders. Philadelphia: W B Saunders, 1995; 705-717.
2. Duane D. Spasmodic torticollis: clinical and biological features and their implications for focal dystonia, In: Fahn S, Marsden CD, Calne DB eds. Dystonia 2. Advances in Neurology, Vol. 50. New York: Raven Press, 1988; 473-492.
3. Cowers WR. Manual of disease of the nervous system. Philadelphia: Blakiston, 1888; 1357.
4. Waddy H, Fletcher NA, Harding AE, Marsden CD. A genetic study of idiopathic focal dystonias. Ann Neurol 1991; 29: 320-324.
5. Fahn S. Clinical variants of idiopathic torsion dystonia. J Neurol Neurosurg Psychiat 1989; 59 (spec. suppl.):96-100.
6. Kwiatkowski DJ, Ozelius L, Kramer PL, Perman S, Schiback DE, Gusella JF, Fahn S, Breakefield XO: Torsion dystonia genes in two populations confined to a small region on chromosome 9q42-44. Am J Hum Genet 1991; 49 (2): 366-371.
7. Bressman S, Warner TT, Almasy L, Uitti RJ, et al. Exclusion of the DYT1 locus in familial torticollis. Ann Neurol 1996; 40: 681-684.
8. Tsui JKC. Cervical dystonia, In: Tsui JKC, Calne DB eds. Handbook of Dystonia. New York: Marcel Dekker, 1995; 115-127.
9. Jankovic J, Fahn S. Dystonic disorders, In: Jarikovic J, Tolosa E eds. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins, 1993; 337-375.
10. Factor S, Podskalny GD, Molho E. Psychogenic movement disorders: frequency, clinical profile and characteristics. J. Neurol Neurosurg Psychiat 1995; 59 (4): 406-412.
11. Fahn S. High - dosage anticholinergic therapy in dystonia. Neurology 1983; 33: 1255-1262.
12. Greene P. Baclofen in the treatment of dystonia. Clin Neuropharmacol 1992; 15: 276-288.
13. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997; 48: 358-362.
14. Stahl S. Neuropharmacology in movement disorders. In: Shah SG, Donald AG eds. Movement Disorders. Baltimore: Plenum Publishing, 1986; 1-34.
15. Friedmann AH, Nashold B, Sharp R, et al. Treatment of spasmodic torticollis with intradural selective rhizotomies. J Neurosurg 1993; 78: 46-53.
16. Tsui JKC, Calne DB. Botulinum toxin in cervical dystonia, In: Jankovic J, Tolosa E. Facial dyskinesias. Advances in Neurology 1988; 49: 473-478.
17. Lees AJ, Turjanski N, Rivest J, Whurr R, Lorch M, Brookes G. Treatment of cervical dystonia, hand spasms and laryngeal dystonia with botulinum toxin. J Neurol 1992; 239: 1-4.
18. Albanese A, Colosimo C, Carretta D, Dickman A, Bentivoglio AR, Tonali P. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm. Eur Neurol 1992; 32: 112-117.
19. Boghen D, Flanders M. Effectiveness of botulinum toxin in the treatment of spasmodic torticollis. Eur Neurol 1993; 33: 199-203.
20. Moore AP, Blumhardt LD. A double blind trial of botulinum toxin A in torticollis, with one year follow up. J Neurol Neurosurg Psychiat 1991; 54: 813-816.
21. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial - cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiat 1990; 53: 633-639.
22. Poewe W, Schelosky L, Kleedorfer B, Keinen F, Wagner M, Deuschl G. Treatment of spasmodic torticollis with local injections of botulinum toxin. One year follow-up in 37 patients. J Neurol 1992; 239: 21-25.
23. Hornykiewicz O, Kish S, Becker L, Farley I, Shannak K. Brain neurotransmitters in dystonia musculorum deformans. N Engl J Med 1986; 315: 347-353.
24. Lehéricy S, Vidailhet M, Dormont D, Piérot L, Chiras J, Mazetti P, Marsault C, Agid Y. Striatopallidal and thalamic dystonia. Arch Neurol 1996; 53: 241-250.
25. Schneider S, Feifel E, Ott D, Schumacher M, Lücking CH, Deuschl G. Prolonged MRI T2 times of the lentiform nucleus in idopathic spasmodic torticollis. Neurology 1994; 44: 846-850.
26. Reilly JA, Hallet M, Cohen LG, Tarkka IM, Dang N. The N30 component of somatosensory evoked potentials in patients with dystonia. Electroencephalogr Clin Neurophysiol 1992; 84: 243-247.
27. Mazzini L, Zaccala L, Balzarini C. Abnormalities of somatosensory evoked potentials in spasmodic torticollis. Mov Disord 1994; 9: 426-430.
28. Fève A, Bathien N, Rondot P. Abnormal movement - related potentials in patients with lesions of basal ganglia and anterior thalamus. J Neurol Neurosurg Psychiat 1994; 57: 100-104.
29. Gelb DJ, Yoshimura DM, Olney RK, Lowenstein DH, Aminoff MJ. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol 1991; 29: 370-376.
30. Marin C, Marti MJ, Tolosa E, Alvarez R, Montserrat L, Santamaria J. Muscle activity changes in spasmodic torticollis after botulinum toxin treatment. Eur J Neurol 1995; 1: 243-247.
31. Kaňovský P, Halačková H, Dufek J. Výsledky komplexni terapie cervikálních dystonií za použití botulotoxinu. Čs Neurol Neurochir 1994; 57: 169-172.
32. Kaňovsky P, Hekerlová R. Cervikální dystonie. Praha: Maxdorf, 1996.
33. Rondot P, Bathien N, Bleton JP, Bragha MC. Le torticollis spasmodique à l'heure de la toxine botulinique. Nevraxe 1992; 4: 3-11.
34. Deuschl G, Keinen F, Kleedorfer B, Wagner M, Lücking CH, Poewe W. Clinical and polymyographic investigation of spasmodic torticollis. J Neurol 1992; 239: 9-15.
35. Tsui JKC, Eisen A, Stoessl AJ, Calne S, Calne DB. Double - blind study of botulinum toxin in spasmodic torticollis. Lancet 1986; 8501: 245-247.
36. Fuglsang-Frederiksen A, Sjö O, Winkel H. Quantitative electromyography as a guidance for botulinum toxin treatment of torticollis patients. Muscle Nerve 1991; 14: 895.
37. Finsterer J, Fuchs I, Mamoli B. Quantitative electromyography - guided botulinum toxin treatment of cervical dystonia. Clin Neuropharmacol 1997; 20: 42-48.
38. Schantz EJ, Johnson EA. Preparation and characterization of botulinum toxin type A for human treatment, In: Jankovic J, Hallet M eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994; 41-51.
39. Durif F. Clinical bioequivalence of the current commercial preparations of botulinum toxin A. Eur J Neurol 1995; 2 (suppl. 1): 17-18.
40. Moyer ED, Setler PE. Pharmacology of botulinum toxin, In: Tsui JKC, Calne DB eds. Handbook of dystonia. New York: Marcel Dekker, 1995; 367-390.
41. Lange DJ, Rubin M, Greene PE, Kang UJ, Moskowitz CC, Brin MF. Distant effects of locally injected botulinum toxin: a double - blind study of single-fiber EMG. Muscle Nerve 1991; 14: 672-675.
42. Simpson LL. The origin, structure and pharmacological activity of botulinum toxin. Pharmacol Rev 1981; 33: 155-188.
43. Priori A, Berardelli A, Mercuri B, Manfredi M. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Brain 1995; 118: 801-807.
44. Hinse P, Leplow B, Humbert T. Impairment of visuos-patial function in idopathic spasmodic torticollis. J Neurol 1996; 243: 29-33.
45. Rothwell JC. The physiology of dystonia, In: Tsui JKC, Calne DB eds. Handbook of dystonia. New York: Marcel Dekker, 1995; 59-75.
46. Bertrand CM, Lenz FA. Surgical treatment of dystonias, In: Tsui JKC, Calne DB eds. Handbook of dystonia. New York: Marcel Dekker, 1995; 329-345.
47. Kaji R. Afferent and feedback effects (abstract). Mov Disord 1995; 10: 365.
48. Hallet M. Is dystonia a sensory disorder? Ann Neurol 1995; 38: 139-140.
49. Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Mov Disord 1991; 6: 119-126.
50. Friedman A, Fahn S. Spontaneous remission in spasmodic torticollis. Neurology 1984; 36 (3): 398-400.
51. Podivinsky F, Torticollis, In: Vinken PJ, Bruyn GW eds. Handbook of clinical Neurology, Amsterdam: Elsevier, Vol. 6, 1968; 567-603.
52. Barclay CL, Lang AE. Psychogenic dystonia, In: Tsui JKC, Calne DB eds. Handbook of dystonia. New York: Marcel Dekker, 1995; 297-298.